News
February 5, 2019

Regenstrief Scientist Says African Americans Have Higher Rate of Alzheimer’s Disease, Quoted in USA Today

Daniel Bateman, M.D., says a number of studies show a higher rate of Alzheimer’s disease in African Americans. He told USA Today there are some hypotheses to explain this.

“There are higher rates of diabetes, hypertension, high cholesterol, heart disease and diabetes in African Americans compared to whites. All of those are risk factors for Alzheimer’s and dementia,” said Dr. Bateman. He points to a 2018 study, which also looked at a number of factors of people who have had a stroke, that found that African Americans had an increased rate for all five types of dementia.

Joanne Pike, vice president of programs for the Alzheimer’s Association in Chicago, says that African Americans are twice as likely to have Alzheimer’s, less likely to receive a diagnosis and more likely to be diagnosed in later stages of the disease. Researchers are looking at many avenues to understand the reasons why.

Regenstrief Institute does a large amount of work in the area of Alzheimer’s and dementia. From testing new care models to decision support and the effects of medication on the brain.  Dr. Bateman’s work is focused on Alzheimer’s disease, specifically innovative approaches to measure and treat behavioral and psychological symptoms of dementia by leveraging technologies. He serves as a co-investigator on the Indiana Alzheimer Disease Center (IADC) Outreach and Recruitment (OR) Core and contributes to the IADC Clinical Core.

Read the USA Today article featuring Dr. Bateman here.

  • Daniel Bateman

Related News

Regenstrief Institute and Suki partner to evaluate ambient AI in healthcare

Organizations share a commitment to understanding how ambient AI technologies impact clinicians, patients and healthcare delivery  Regenstrief Institute and Suki, a

Dr. Peter J. Embi

Regenstrief’s legacy with the National Library of Medicine continues

Peter J. Embí, M.D., M.S., former president and CEO of the Regenstrief Institute, has been appointed director of the

image showing two people connecting through a kidney

Regenstrief Institute awarded KidneyX prize to advance living kidney donation

LIVINGkidney digital tool recognized in national HHS competition focused on reducing barriers for living kidney donors and transplant patients  Regenstrief

LOINC® version 2.83 enhances global health data exchange through new terminology and implementation improvements

Release expands terminology for drug and toxicology testing, microbiology, public health reporting and allergy information Regenstrief Institute has released